OKLAHOMA CITY – CorriXR Therapeutics, Inc. (“CorriXR”), a biotherapeutics company developing unique genetic medicines that optimize the effectiveness of existing cancer treatments by knocking out genes responsible for resistance, today announced the appointment of Jill Castilla to its Board of Directors. Ms. Castilla brings visionary leadership as a nationally recognized innovator in finance and banking. “We are very pleased to welcome Jill to our Board … Continue reading CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors

Veteran drug developer and R&D leader with three decades of pharmaceutical and biotech experience to oversee development of targeted protein enhancement modality WATERTOWN, Mass. – Entact Bio, a company committed to improving the lives of patients by developing precision medicines that enhance the function of beneficial proteins, today announced the appointment of Ruben Tommasi, Ph.D., as Chief Scientific Officer. Dr. Tommasi joins Entact with three … Continue reading Entact Bio Appoints Ruben Tommasi, Ph.D., as Chief Scientific Officer

SAN DIEGO – Mirador Therapeutics, Inc., a next-generation precision medicine company focused on developing first-in-class or best-in-class therapeutics for immunology and inflammation (I&I), today announced the appointment of Gregg Gilbert as chief financial officer. Mr. Gilbert brings more than 25 years of leadership experience in biopharma equity research analysis and investment banking to the role. “Since launching earlier this year with over $400 million in … Continue reading Mirador Therapeutics Appoints Gregg Gilbert as Chief Financial Officer

IRVINE, Calif. – BioDuro-Sundia, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to announce the appointment of Dr. Armin Spura as its new Chief Executive Officer. Dr. Spura brings over two decades of experience in the life sciences and biotechnology sectors, with a proven track record of driving growth and innovation across global markets. With our CRDMO platform encompassing chemistry, biology, DMPK, … Continue reading BioDuro-Sundia Appoints Dr. Armin Spura as New Chief Executive Officer

Funding will Advance Cellino’s Advanced Biomanufacturing Technology for Personalized Regenerative Medicines CAMBRIDGE, Mass. – Cellino Biotech, Inc. today announced that the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, has awarded it up to $25 million in funding to develop an ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicines. Cellino’s NEBULA (NExt-generation Biomanufacturing ULtra-scalable … Continue reading Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H)